Muse bio secures $23M Series B funding led by Venrock investor group

Muse bio secures $23M Series B funding led by Venrock investor group

BOULDER -- Muse bio , a privately-held company leading the development of next-generation genome engineering capabilities, today announced completion of a$23 millionSeries B financing. The... Read More

Tuesday February 28, 2017 0 comments Tags: Boulder, Muse bio, Venrock, Bryan Roberts, Dr. Kevin Ness, ForgeCraft